サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1291598

がん/腫瘍プロファイリング市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
がん/腫瘍プロファイリング市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん/腫瘍プロファイリング市場規模は、2022年に104億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に9.8%の成長率（CAGR）を示し、2028年までに184億米ドルに達すると予測しています。

がん/腫瘍プロファイリングは、バイオマーカー検査としても知られ、腫瘍組織サンプル中の特定のタンパク質、遺伝子、遺伝子変異（変化）、その他のバイオマーカーを特定するために用いられる実験室検査または手順のことを指します。患者さんの腫瘍の経路が、利用可能な標的治療薬と一致するかどうかを判断する際に、腫瘍医を支援するものです。また、日常的な診断、治療の意思決定、病気の重症度やゲノムの蓄積に基づく個人のための個別化治療計画や治療法の開発にも役立っています。また、がん/腫瘍プロファイリングは、個別化医療、研究、バイオマーカーの発見、スクリーニングや診断技術の開発など、幅広い用途で活用されています。

がん/腫瘍プロファイリングの市場動向：

がん/腫瘍プロファイリングは、腫瘍学研究、薬剤設計・発見・開発の過程におけるバイオマーカー探索に広く利用されています。その結果、世界中でがんが広く蔓延していることが、市場成長を促進する主要因となっています。また、診断や腫瘍のプロファイリングを目的としたバイオマーカーへの注目が高まっていることや、大衆の間で個別化医療への嗜好が変化していることも、製品の需要を高めています。さらに、腫瘍の検出と特定にかかる時間を短縮するための高度な技術の開発のために、がん研究に対する政府の資金援助や支援が大幅に増加しました。これとともに、次世代シーケンサー（NGS）などの分子生物学的技術の最近の進歩が、がん/腫瘍プロファイリングの採用を加速しています。さらに、製薬会社やバイオテクノロジー企業が、新規治療薬や新薬設計技術の上市に向けた研究開発活動への投資を増やしていることも、市場の成長を後押ししています。その他、臨床試験数の増加、イムノアッセイ技術の採用拡大、有利な償還政策、ヘルスケアインフラの改善、技術の進歩なども、市場に明るい展望をもたらしています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 がん/腫瘍プロファイリングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 がんタイプ別市場内訳

  • 乳がん
    • 市場動向
    • 市場予測
  • 肺がん
    • 市場動向
    • 市場予測
  • 大腸がん
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • メラノーマ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 技術別市場内訳

  • 次世代シーケンサー（NGS）
    • 市場動向
    • 市場予測
  • ポリメラーゼ連鎖反応（PCR）
    • 市場動向
    • 市場予測
  • 免疫組織化学（IHC）
    • 市場動向
    • 市場予測
  • インサイチュハイブリダイゼーション（ISH）
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 技術別市場内訳

  • ゲノミクス
    • 市場動向
    • 市場予測
  • プロテオミクス
    • 市場動向
    • 市場予測
  • エピジェネティクス
    • 市場動向
    • 市場予測
  • メタボロミクス
    • 市場動向
    • 市場予測

第9章 アプリケーション別市場内訳

  • 個別化医療
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • バイオマーカー探索
    • 市場動向
    • 市場予測
  • プログノスティックス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会（Opportunities
  • 脅威（Treats

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Caris Life Sciences
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • HTG Molecular Diagnostics Inc.
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • NeoGenomics Laboratories
    • Qiagen N.V.
    • Siemens AG
    • Sysmex Corporation
図表

List of Figures

  • Figure 1: Global: Cancer/Tumor Profiling Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer/Tumor Profiling Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cancer/Tumor Profiling Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Cancer/Tumor Profiling Market: Breakup by Cancer Type (in %), 2022
  • Figure 5: Global: Cancer/Tumor Profiling Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Cancer/Tumor Profiling Market: Breakup by Technique (in %), 2022
  • Figure 7: Global: Cancer/Tumor Profiling Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Cancer/Tumor Profiling Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Cancer/Tumor Profiling (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Cancer/Tumor Profiling (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Cancer/Tumor Profiling (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Cancer/Tumor Profiling (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Cancer/Tumor Profiling (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Cancer/Tumor Profiling (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Cancer/Tumor Profiling (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Cancer/Tumor Profiling (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Cancer/Tumor Profiling (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Cancer/Tumor Profiling (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Cancer/Tumor Profiling (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Cancer/Tumor Profiling (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Cancer/Tumor Profiling (Genomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Cancer/Tumor Profiling (Genomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Cancer/Tumor Profiling (Proteomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Cancer/Tumor Profiling (Proteomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Cancer/Tumor Profiling (Epigenetics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Cancer/Tumor Profiling (Epigenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Cancer/Tumor Profiling (Metabolomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Cancer/Tumor Profiling (Metabolomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Cancer/Tumor Profiling (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Cancer/Tumor Profiling (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Cancer/Tumor Profiling (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Cancer/Tumor Profiling (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Cancer/Tumor Profiling (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Cancer/Tumor Profiling (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Cancer/Tumor Profiling (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Cancer/Tumor Profiling (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: North America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: North America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United States: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United States: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Canada: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Canada: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Asia-Pacific: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Asia-Pacific: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: China: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: China: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Japan: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Japan: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: India: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: India: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: South Korea: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: South Korea: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Australia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Australia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Indonesia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Indonesia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Europe: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Germany: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Germany: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: France: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: France: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: United Kingdom: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: United Kingdom: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Italy: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Italy: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Spain: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Spain: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Russia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Russia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Latin America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Latin America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Brazil: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Brazil: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Mexico: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Mexico: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Middle East and Africa: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Middle East and Africa: Cancer/Tumor Profiling Market: Breakup by Country (in %), 2022
  • Figure 99: Middle East and Africa: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Global: Cancer/Tumor Profiling Industry: SWOT Analysis
  • Figure 101: Global: Cancer/Tumor Profiling Industry: Value Chain Analysis
  • Figure 102: Global: Cancer/Tumor Profiling Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer/Tumor Profiling Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 3: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technique (in Million US$), 2023-2028
  • Table 5: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Cancer/Tumor Profiling Market: Competitive Structure
  • Table 8: Global: Cancer/Tumor Profiling Market: Key Players
目次
Product Code: SR112023A5231

The global cancer/tumor profiling market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.

Cancer/tumor profiling, also known as biomarker testing, refers to a laboratory test or procedure used to identify specific proteins, genes or gene mutations (changes) and other biomarkers in a tumor tissue sample. It assists oncologists in determining if the pathways of a patient's tumor match up with the available targeted therapies. It also aids in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals based on the severity of their ailment and genomic build-up. Cancer/tumor profiling also finds extensive applications in personalized medicine, research, the discovery of biomarkers, and the development of screening and diagnostic techniques.

Cancer/Tumor Profiling Market Trends:

Cancer/tumor profiling is widely used in oncology research and discovery of biomarkers during the process of drug design, discovery and development. As a result, the widespread prevalence of cancer across the globe represents the primary factor driving the market growth. Besides this, the growing focus on biomarkers for diagnosis and tumor profiling and the shifting preferences toward personalized medicine among the masses are augmenting the product demand. Additionally, there has been a significant rise in government funding and support for cancer research for the development of advanced techniques to reduce the time taken for the detection and identification of tumors. Along with this, the recent advancements in molecular biology techniques, such as next-generation sequencing (NGS), are accelerating the adoption of cancer/tumor profiling. Furthermore, the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for the launch of novel therapies and new drug designing techniques are propelling the market growth. Other factors, including the rising number of clinical trials, growing adoption of immunoassay techniques, favorable reimbursement policies, improving healthcare infrastructure, and technological advancements, are also creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer/tumor profiling market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, technology, technique and application.

Breakup by Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma Cancer

Others

Breakup by Technology:

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In-Situ Hybridization (ISH)

Microarray

Others

Breakup by Technique:

Genomics

Proteomics

Epigenetics

Metabolomics

Breakup by Application:

Personalized Medicine

Diagnostics

Biomarker Discovery

Prognostics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

1. What was the size of the global cancer/tumor profiling market in 2022?

2. What is the expected growth rate of the global cancer/tumor profiling market during 2023-2028?

3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?

4. What are the key factors driving the global cancer/tumor profiling market?

5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?

6. What is the breakup of the global cancer/tumor profiling market based on the technique?

7. What are the key regions in the global cancer/tumor profiling market?

8. Who are the key players/companies in the global cancer/tumor profiling market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Cancer/Tumor Profiling Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Cancer Type

  • 6.1  Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Lung Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Prostate Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Melanoma Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7   Market Breakup by Technology

  • 7.1  Next-Generation Sequencing (NGS)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Polymerase Chain Reaction (PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Immunohistochemistry (IHC)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  In-Situ Hybridization (ISH)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Microarray
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8   Market Breakup by Technique

  • 8.1  Genomics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Proteomics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Epigenetics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Metabolomics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Personalized Medicine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Biomarker Discovery
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Prognostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3  Caris Life Sciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Exact Sciences Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6  Hologic Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  HTG Molecular Diagnostics Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8  Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Laboratory Corporation of America Holdings
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  NeoGenomics Laboratories
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11  Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  Siemens AG
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13  Sysmex Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis